Universität Münster
Welcome,         Profile    Billing    Logout  
 8 Trials 
18 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Eter, Nicole
NCT05002998: TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study

Active, not recruiting
4
313
Europe, US
Teprotumumab, TEPEZZA, Placebo, Saline Solution
Amgen
Thyroid Eye Disease
04/26
04/26
SALUS, NCT04698876: Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation

Completed
N/A
267
Europe
Self-tonometry by means of ICareHOME, Intraocular measurement by means of rebound tonometry or Goldmann applanation tonometry, Blood pressure
University Hospital Muenster, Federal Joint Committee, Bielefeld University, Fraunhofer Institute for Applied Information Technology FIT, KVWL, BARMER, DAK Gesundheit, IKK, AOK PLUS
Glaucoma, Intraocular Pressure, Patient Empowerment, Telemedicine
10/23
11/23
PRIMAvera, NCT04676854: Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD

Active, not recruiting
N/A
38
Europe
PRIMA Bionic Vision System
Science Corporation
Geographic Atrophy
02/24
02/28
EyeMatics, NCT06810011: Eye Diseases "Treated" with Interoperable Medical Informatics

Recruiting
N/A
2000
Europe
University Hospital Muenster, University Medicine Greifswald, University Medical Center Mainz, University Hospital, Aachen, Klinikum Chemnitz gGmbH, Technische Universität Dresden, University of Leipzig, University Hospital Tuebingen, Deutsche Ophthalmologische Gesellschaft e.V., Pro Retina Deutschland e.V.
Intravitreal Injections
02/28
02/28
INTERCEPT-AMD, NCT05698316: A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression

Active, not recruiting
N/A
1000
Europe
Collection of both retrospective and prospective data collection in 3 visits.
Association for Innovation and Biomedical Research on Light and Image, European Vision Institute Clinical Research Network
Age Related Macular Degeneration, Intermediate AMD, Atrophy, Prediction
02/24
04/25
Trebicka, Jonel
CARP, NCT05551299: Treatment of Non-resectable Bile Duct Cancer With Radiofrequency Ablation or Photodynamic Therapy

Recruiting
4
258
Europe
Photosensitizer, Photodynamic therapy (PDT), Radiofrequency ablation (RFA)
University of Leipzig, Zentrum für Klinische Studien Leipzig
Hilar Cholangiocarcinoma
04/28
04/28
PRECIOSA, NCT03451292 / 2016-001789-28: Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites

Completed
3
410
Europe, Canada, US, RoW
Albutein 20% Injectable Solution, Standard medical treatment
Grifols Therapeutics LLC, Instituto Grifols, S.A.
Decompensated Cirrhosis and Ascites
05/24
05/24
NCT04950127 / 2021-000007-21: Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)

Active, not recruiting
3
238
Europe, Canada, Japan, US, RoW
Linerixibat, Placebo
GlaxoSmithKline
Pruritus
10/24
01/25
NCT05056220: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

Recruiting
3
240
Europe
Human albumin, sodium chloride
Aleksander Krag, EASL - CLIF Consortium
Decompensated Cirrhosis and Ascites
03/25
04/25
APACHE, NCT03702920 / 2016-001787-10: Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5%

Recruiting
3
380
Europe, US
SMT + PE-A 5%, Albutein 5%, Standard Medical Treatment, SMT
Grifols Therapeutics LLC, Instituto Grifols, S.A.
Acute-On-Chronic Liver Failure
10/26
10/26
LLSAT, NCT04167358 / 2019-003158-10: Linerixibat Long-term Safety, and Tolerability Study

Recruiting
3
251
Europe, Canada, Japan, US, RoW
Linerixibat
GlaxoSmithKline, GlaxoSmithKline LLC, GlaxoSmithKline Research & Development Limited
Cholestasis
02/27
02/27
COMBAT, NCT05895136: A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome ( Trial).

Recruiting
2
90
Europe
Human albumin, Enoxaparin, Standard medical treatment
European Foundation for Study of Chronic Liver Failure
Liver Cirrhosis
03/25
03/25
DETECT, NCT06523608: Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease

Recruiting
N/A
600
Europe
Standard survillance protocol, Stratified survillance protocol
University Hospital Muenster
Liver Diseases, Hepatocellular Carcinoma, Hepatocarcinoma, Advanced Chronic Liver Disease
09/25
09/27
Liver-HERO, NCT05346393: HRS-AKI Treatment With TIPS in Patients With Cirrhosis

Recruiting
N/A
124
Europe
TIPS, Standard of Care, Terlipressin + Albumin
Jena University Hospital, German Research Foundation, University Hospital Halle (Saale)
Cirrhosis, Liver, Hepatorenal Syndrome, Acute Kidney Injury, Ascites Hepatic
06/25
06/26
NCT03584204: Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome

Recruiting
N/A
400
Europe
imaging
University Hospital, Bonn, University of Roma La Sapienza
Liver Cirrhosis
07/25
08/26
ACLF-I, NCT04975490: Characterization and Pathogenesis of ACLF

Recruiting
N/A
1000
Europe
Johann Wolfgang Goethe University Hospital
Liver Cirrhosis, Acute-On-Chronic Liver Failure, Portal Hypertension
09/25
12/25
CHANCE, NCT04613921: Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs

Recruiting
N/A
3000
Europe, Canada, Japan, US, RoW
Observational Protocol
European Foundation for Study of Chronic Liver Failure
Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications
12/25
12/26
NCT05661331: VIATORR Device Registry

Recruiting
N/A
196
Europe
Transjugular intrahepatic portosystemic shunt, TIPS
W.L.Gore & Associates
Chronic Liver Disease
01/25
01/28

Download Options